Gunnar Telhammar
Director of Finance/CFO at XINTELA AB
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Evy Lundgren-Åkerlund | M | 67 |
Targinta AB
 Targinta AB BiotechnologyHealth Technology Part of Xintela AB, Targinta AB develops targeting and toxin-armed antibodies for cancer. The private company is based in Lund, Sweden. Peter Ekolind has been the CEO of the Swedish company since 2022. | 15 years |
| Sofie Woge | F | - | 8 years | |
| Shahram Lavasani | M | - |
ImmuneBiotech Medical Sweden AB
 ImmuneBiotech Medical Sweden AB Pharmaceuticals: MajorHealth Technology ImmuneBiotech Medical Sweden AB engages in the development of novel probiotics for therapeutic effects. It offers ImmuneBiotics, probiotics for achieving balance between the microbiome, the immune system, and the intestinal barrier. The company was founded by Shahram Lavasani and Mehrnaz Nouri and is headquartered in Lund, Sweden. | - |
| Stefan Scheding | M | 62 | 12 years | |
| Maarten de Château | M | 61 |
Targinta AB
Targinta AB BiotechnologyHealth Technology Part of Xintela AB, Targinta AB develops targeting and toxin-armed antibodies for cancer. The private company is based in Lund, Sweden. Peter Ekolind has been the CEO of the Swedish company since 2022. | 3 years |
| Martin Linde | M | 53 | 7 years | |
| Derek Gregory Batcheller | M | 67 |
Targinta AB
Targinta AB BiotechnologyHealth Technology Part of Xintela AB, Targinta AB develops targeting and toxin-armed antibodies for cancer. The private company is based in Lund, Sweden. Peter Ekolind has been the CEO of the Swedish company since 2022.
ImmuneBiotech Medical Sweden AB
ImmuneBiotech Medical Sweden AB Pharmaceuticals: MajorHealth Technology ImmuneBiotech Medical Sweden AB engages in the development of novel probiotics for therapeutic effects. It offers ImmuneBiotics, probiotics for achieving balance between the microbiome, the immune system, and the intestinal barrier. The company was founded by Shahram Lavasani and Mehrnaz Nouri and is headquartered in Lund, Sweden. | 13 years |
| Lars Thomas Laurell | M | 63 | 13 years | |
| Mehrnaz Nouri | M | - |
ImmuneBiotech Medical Sweden AB
ImmuneBiotech Medical Sweden AB Pharmaceuticals: MajorHealth Technology ImmuneBiotech Medical Sweden AB engages in the development of novel probiotics for therapeutic effects. It offers ImmuneBiotics, probiotics for achieving balance between the microbiome, the immune system, and the intestinal barrier. The company was founded by Shahram Lavasani and Mehrnaz Nouri and is headquartered in Lund, Sweden. | - |
| Hans-Joachim Simons | M | 62 | 2 years | |
| Per Anders Hedin | M | - | - | |
| Lucienne Vonk | M | 43 | - | |
| Martin Olin | M | 55 | 3 years | |
| Thomas Bengt Eldered | M | 64 | 2 years | |
| Katherine J. Flagg | F | - | 3 years | |
| Torsten Freltoft | M | 66 | 10 years | |
| Lars Olof Hedbys | M | 67 | 3 years | |
| Peter Arndt | M | 57 | 2 years | |
| Pontus Renmarker | M | 34 | 4 years | |
| Wendi Ma | M | - | - | |
| Robin Gustafsson | M | 36 | 4 years | |
| Henrik Nilsson | M | - | - | |
| Bengt Söderberg | M | 67 | 2 years | |
| Anna-Tove Brånemark | F | 57 | 2 years | |
| Tomas Leanderson | M | 68 |
University of Lund
| 34 years |
| Johan Granath | M | - | - | |
| Haqvin Svensson | M | - | 5 years | |
| Lars Johan Möllerström | M | 57 | - | |
| Catharina Svanborg | M | 75 |
University of Lund
| 35 years |
| Peter Forssberg | M | 76 | - | |
| Petr Dejmek | M | 79 |
University of Lund
| 35 years |
| Mette Gross | F | 52 | 2 years | |
| Thomas Areschoug | M | 52 | 7 years | |
| Guido Zacchi | M | 74 |
University of Lund
| 35 years |
| Peter Ekolind | M | 60 |
Targinta AB
Targinta AB BiotechnologyHealth Technology Part of Xintela AB, Targinta AB develops targeting and toxin-armed antibodies for cancer. The private company is based in Lund, Sweden. Peter Ekolind has been the CEO of the Swedish company since 2022. | 2 years |
| Lars Magnus Thomas Bjursten | M | 75 |
University of Lund
| 35 years |
| Karin Larsson | M | - |
ImmuneBiotech Medical Sweden AB
ImmuneBiotech Medical Sweden AB Pharmaceuticals: MajorHealth Technology ImmuneBiotech Medical Sweden AB engages in the development of novel probiotics for therapeutic effects. It offers ImmuneBiotics, probiotics for achieving balance between the microbiome, the immune system, and the intestinal barrier. The company was founded by Shahram Lavasani and Mehrnaz Nouri and is headquartered in Lund, Sweden. | 8 years |
| Pia Suzanne Kinhult | F | 65 | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Sven Kili | M | 57 | 8 years | |
| Ulrika Ringdahl | F | - |
University of Lund
| 11 years |
| Per Norlén | M | 54 |
Targinta AB
Targinta AB BiotechnologyHealth Technology Part of Xintela AB, Targinta AB develops targeting and toxin-armed antibodies for cancer. The private company is based in Lund, Sweden. Peter Ekolind has been the CEO of the Swedish company since 2022. | 1 years |
| Jan Staffan Helgesson | M | 56 |
University of Lund
| 4 years |
| Sven Anders Mikael Akke | M | 63 |
University of Lund
| 3 years |
| Jan Talts | M | 59 | 5 years | |
| Ming Hua Li | M | 73 |
University of Lund
| 3 years |
| Anders Thorsson | M | 57 |
University of Lund
| 1 years |
| Gunilla Andersson | F | 63 |
University of Lund
| 4 years |
| Jonas Måhlén | M | 56 |
University of Lund
| 6 years |
| Fredrik Wetterlundh | M | 58 |
University of Lund
| 3 years |
| Keld Søndergaard | M | - | - | |
| Mats Säterberg | M | 61 |
University of Lund
| 4 years |
| Carl Magnus Högerkorp | M | 54 | 1 years | |
| Sven Erik Holmgren | M | 63 |
University of Lund
| 3 years |
| Per Stefan Andersson-Engels | M | 64 |
University of Lund
| 3 years |
| Anders Runevad | M | 64 |
University of Lund
| 4 years |
| Staffan Mattson | M | 62 |
University of Lund
| 1 years |
| Anna Maria Inga Söderblom | M | 61 |
University of Lund
| 4 years |
| Peter Sandin | M | 57 |
University of Lund
| 1 years |
| Mats Svensson | M | 60 |
University of Lund
| 4 years |
| Per Johan Anell | M | 56 |
University of Lund
| 4 years |
| Erik B. Larsson | M | 57 |
University of Lund
| 4 years |
| Sven Nordholm | M | - |
University of Lund
| 3 years |
| Carmen Valcarce | M | - |
University of Lund
| 9 years |
| Karl Stefan Olofsson | M | 56 |
University of Lund
| 4 years |
| Claes Tomas Post | M | 74 | 7 years | |
| Tobias Järnblad | M | - |
University of Lund
| 4 years |
| Karin Helena Johansson Wingstrand | F | 67 | 8 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Sweden | 67 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Gunnar Telhammar
- Personal Network